Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.185 USD
−110.56 M USD
127.04 M USD
151.02 M
About Heron Therapeutics, Inc.
Sector
Industry
CEO
Craig A. Collard
Website
Headquarters
San Diego
Founded
1983
FIGI
BBG00JVXD337
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
HRTX - Biotech long play Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Investment Snapshot (As o
$HRTX Inverse head and shouldersNot financial advice.
NASDAQ:HRTX possible inverse heads and shoulders. broke the downtrend line. will see if goes up to complete the neck.
Like and subscribe for more ideas.
Thanks.
HRTX a biotech penny stock with 70% in two months LONGHRTX has been suggested by various trading websites as a potentially explosive penny biotech
stock for 2024. It has experienced excellent price actions since an earnings beat in November.
It beat the estimates; that is to say it burned about half as much cash as the analysts estimated
the it wou
Liking this setup here, double bottom bullish divergenceWeekly timeframe RSI reminds me a Lot of Coinbase before it mega mooned.
In the context of the monthly timeframe, look where we are, all time lows. and bullish DIV on the MACD.
I don't know anything about this stock, just looking at the chart.
#HRTX $HRTX watching for continuation 👌nice trend with higher lows, is approaching resistance zone. a break of this can send it on parabolic move to upside.
short term targets are 3.7-3.86+
Potential rocket on 50-100%Heron Therapeutics, Inc - a biotech company whose main products are drugs for nausea and vomiting caused by chemotherapy (CINV), as well as painkillers. Capitalization of $1.2 billion. Located in San Diego, USA.
In May of this year, the company received FDA approval for its "breakthrough" pain medi
HRTX - Areas of interestThere are very clearly visible daily order blocks on both side of the price. Wait for price to come to those zones and then look for rejection on a smaller time frame - then trade along.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0J4V is 1.601 USD — it has increased by 5.32% in the past 24 hours. Watch HERON THERAPEUTICS INC COM USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HERON THERAPEUTICS INC COM USD0.01 stocks are traded under the ticker 0J4V.
0J4V stock has risen by 3.87% compared to the previous week, the month change is a 38.01% rise, over the last year HERON THERAPEUTICS INC COM USD0.01 has showed a −5.20% decrease.
We've gathered analysts' opinions on HERON THERAPEUTICS INC COM USD0.01 future price: according to them, 0J4V price has a max estimate of 9.00 USD and a min estimate of 4.00 USD. Watch 0J4V chart and read a more detailed HERON THERAPEUTICS INC COM USD0.01 stock forecast: see what analysts think of HERON THERAPEUTICS INC COM USD0.01 and suggest that you do with its stocks.
0J4V reached its all-time high on Jul 9, 2018 with the price of 41.150 USD, and its all-time low was 0.556 USD and was reached on Nov 10, 2023. View more price dynamics on 0J4V chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0J4V stock is 10.36% volatile and has beta coefficient of 1.02. Track HERON THERAPEUTICS INC COM USD0.01 stock price on the chart and check out the list of the most volatile stocks — is HERON THERAPEUTICS INC COM USD0.01 there?
Today HERON THERAPEUTICS INC COM USD0.01 has the market capitalization of 240.31 M, it has decreased by −2.37% over the last week.
Yes, you can track HERON THERAPEUTICS INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
HERON THERAPEUTICS INC COM USD0.01 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
0J4V earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.04 USD resulting in a 20.79% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about HERON THERAPEUTICS INC COM USD0.01 earnings.
HERON THERAPEUTICS INC COM USD0.01 revenue for the last quarter amounts to 32.81 M USD, despite the estimated figure of 36.77 M USD. In the next quarter, revenue is expected to reach 37.29 M USD.
0J4V net income for the last quarter is −4.85 M USD, while the quarter before that showed −9.23 M USD of net income which accounts for 47.50% change. Track more HERON THERAPEUTICS INC COM USD0.01 financial stats to get the full picture.
No, 0J4V doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 126.00 employees. See our rating of the largest employees — is HERON THERAPEUTICS INC COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HERON THERAPEUTICS INC COM USD0.01 EBITDA is −23.30 M USD, and current EBITDA margin is −84.79%. See more stats in HERON THERAPEUTICS INC COM USD0.01 financial statements.
Like other stocks, 0J4V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HERON THERAPEUTICS INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HERON THERAPEUTICS INC COM USD0.01 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HERON THERAPEUTICS INC COM USD0.01 stock shows the sell signal. See more of HERON THERAPEUTICS INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.